TY - JOUR
T1 - Pathological findings associated with the updated European Society of Cardiology 2022 guidelines for preoperative cardiac testing
T2 - an observational cohort modelling study
AU - Stroda, Alexandra
AU - Mauermann, Eckhard
AU - Ionescu, Daniela
AU - the MET-REPAIR investigators
AU - Szczeklik, Wojciech
AU - De Hert, Stefan
AU - Filipovic, Miodrag
AU - Beck Schimmer, Beatrice
AU - Spadaro, Savino
AU - Matute, Purificación
AU - Ganter, Michael T.
AU - Ovezov, Alexey
AU - Turhan, Sanem C.
AU - van Waes, Judith
AU - Lagarto, Filipa
AU - Theodoraki, Kassiani
AU - Gupta, Anil
AU - Gillmann, Hans Jörg
AU - Guzzetti, Luca
AU - Kotfis, Katarzyna
AU - Larmann, Jan
AU - Corneci, Dan
AU - Buggy, Donal J.
AU - Howell, Simon J.
AU - Lurati Buse, Giovanna
AU - Kemper, Johann
AU - Kohaupt, Lena
AU - Witzler, Jette
AU - Tuzhikov, Michael
AU - Roth, Sebastian
AU - M'Pembele, René
AU - Tenge, Theresa
AU - Schultze, Cornelia
AU - Verbarg, Nele
AU - Gehrke, Christian
AU - Klemann, Anna Katharina
AU - Hagebölling, Friederike
AU - Albrecht, Svenja
AU - Stroeder, Jakob
AU - Schubert, Ann Kristin
AU - Espeter, Florian
AU - Russe, Benedikt
AU - Weigand, Markus A.
AU - Bergmann, Lars
AU - Unterberg, Matthias
AU - Bischoff, Petra
AU - Pirzer, Raphael
AU - Rach, Patric Rene
AU - Ott, Klaus
AU - Koopman, Seppe
AU - Van Lier, Felix
N1 - Publisher Copyright: © 2024 British Journal of Anaesthesia
PY - 2024/4
Y1 - 2024/4
N2 - Background: In 2022, the European Society of Cardiology updated guidelines for preoperative evaluation. The aims of this study were to quantify: (1) the impact of the updated recommendations on the yield of pathological findings compared with the previous guidelines published in 2014; (2) the impact of preoperative B-type natriuretic peptide (NT-proBNP) use for risk estimation on the yield of pathological findings; and (3) the association between 2022 guideline adherence and outcomes. Methods: This was a secondary analysis of MET-REPAIR, an international, prospective observational cohort study (NCT03016936). Primary endpoints were reduced ejection fraction (EF<40%), stress-induced ischaemia, and major adverse cardiovascular events (MACE). The explanatory variables were class of recommendations for transthoracic echocardiography (TTE), stress imaging, and guideline adherence. We conducted second-order Monte Carlo simulations and multivariable regression. Results: In total, 15,529 patients (39% female, median age 72 [inter-quartile range: 67–78] yr) were included. The 2022 update changed the recommendation for preoperative TTE in 39.7% patients, and for preoperative stress imaging in 12.9% patients. The update resulted in missing 1 EF <40% every 3 fewer conducted TTE, and in 4 additional stress imaging per 1 additionally detected ischaemia events. For cardiac stress testing, four more investigations were performed for every 1 additionally detected ischaemia episodes. Use of NT-proBNP did not improve the yield of pathological findings. Multivariable regression analysis failed to find an association between adherence to the updated guidelines and MACE. Conclusions: The 2022 update for preoperative cardiac testing resulted in a relevant increase in tests receiving a stronger recommendation. The updated recommendations for TTE did not improve the yield of pathological cardiac testing.
AB - Background: In 2022, the European Society of Cardiology updated guidelines for preoperative evaluation. The aims of this study were to quantify: (1) the impact of the updated recommendations on the yield of pathological findings compared with the previous guidelines published in 2014; (2) the impact of preoperative B-type natriuretic peptide (NT-proBNP) use for risk estimation on the yield of pathological findings; and (3) the association between 2022 guideline adherence and outcomes. Methods: This was a secondary analysis of MET-REPAIR, an international, prospective observational cohort study (NCT03016936). Primary endpoints were reduced ejection fraction (EF<40%), stress-induced ischaemia, and major adverse cardiovascular events (MACE). The explanatory variables were class of recommendations for transthoracic echocardiography (TTE), stress imaging, and guideline adherence. We conducted second-order Monte Carlo simulations and multivariable regression. Results: In total, 15,529 patients (39% female, median age 72 [inter-quartile range: 67–78] yr) were included. The 2022 update changed the recommendation for preoperative TTE in 39.7% patients, and for preoperative stress imaging in 12.9% patients. The update resulted in missing 1 EF <40% every 3 fewer conducted TTE, and in 4 additional stress imaging per 1 additionally detected ischaemia events. For cardiac stress testing, four more investigations were performed for every 1 additionally detected ischaemia episodes. Use of NT-proBNP did not improve the yield of pathological findings. Multivariable regression analysis failed to find an association between adherence to the updated guidelines and MACE. Conclusions: The 2022 update for preoperative cardiac testing resulted in a relevant increase in tests receiving a stronger recommendation. The updated recommendations for TTE did not improve the yield of pathological cardiac testing.
UR - http://www.scopus.com/inward/record.url?scp=85184759945&partnerID=8YFLogxK
U2 - 10.1016/j.bja.2023.12.036
DO - 10.1016/j.bja.2023.12.036
M3 - Article
C2 - 38336516
AN - SCOPUS:85184759945
SN - 0007-0912
VL - 132
SP - 675
EP - 684
JO - British Journal of Anaesthesia
JF - British Journal of Anaesthesia
IS - 4
ER -